.png)
.png)
Senior Director, Microbiology & Surveillance
JMI Laboratories
Disclosure(s): AbbVie: Grant/Research Support; Cidara: Grant/Research Support; Melinta: Grant/Research Support; Nabriva Therapeutics: Grant/Research Support; Pfizer: Grant/Research Support
Dr. Sader completed his medical school training and Master’s degree in Infectious Diseases at the Federal University of São Paulo (UNIFESP), São Paulo, Brazil and trained in Clinical Microbiology in the Department of Pathology at the University of Iowa with professors Ronald Jones and Michael Pfaller. After completing the Ph.D. program in December 1993, Dr. Sader achieved the position of Professor of Medicine (Infectious Diseases) at the UNIFESP. Dr. Helio Sader joined JMI Laboratories in 2003 and has primarily worked on national and global surveillance programs and new drug development. He is responsible for designing and overseeing antimicrobial surveillance studies and new drug development projects. His work encompasses scientific research, data analysis and medical writing. Dr. Sader is also responsible for the preparation of abstracts/poster for scientific meetings and manuscripts for submission to peer-reviewed journals. Dr. Sader has authored more than 550 peer-reviewed articles and 25 book chapters.